Edwards Lifesciences's market cap is currently $44.47B. The company's EPS TTM is $0.67; its P/E ratio is 51.33; Edwards Lifesciences is scheduled to report earnings on July 24, 2025, and the estimated EPS forecast is $0.59. See an overview of income statement, balance sheet, and cash flow financials.
